Our results are supported by a recent study that showed that a phosphorylated form of LSD1 (p-LSD1) at Ser111 was enriched in docetaxel-resistant breast cancer cell lines and both LSD1 and p-LSD1 were upregulated in tumor cells surviving taxane-therapy in mouse xenografts [32]. The gene discussed is KDM1A; the disease is breast cancer.